Cost of Revenue of ORAMED PHARMACEUTICALS INC. from 29 Feb 2016 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
ORAMED PHARMACEUTICALS INC. quarterly and annual Cost of Revenue in USD history and change rate from 29 Feb 2016 to 31 Mar 2025.
  • ORAMED PHARMACEUTICALS INC. Cost of Revenue for the quarter ending 31 Mar 2025 was $1,987,000.
  • ORAMED PHARMACEUTICALS INC. annual Cost of Revenue for 2019 was $90,000.
  • ORAMED PHARMACEUTICALS INC. annual Cost of Revenue for 2018 was $86,000, a 146% decline from 2017.
  • ORAMED PHARMACEUTICALS INC. annual Cost of Revenue for 2017 was $187,000, a 62% decline from 2016.
Source SEC data
View on sec.gov
Cost of Revenue, Quarterly (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,987,000 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2019 $55,000 01 Dec 2018 28 Feb 2019 10-Q 06 Apr 2020 2020 Q2
Q4 2018 $35,000 01 Sep 2018 30 Nov 2018 10-Q 09 Jan 2020 2020 Q1
Q2 2018 $86,000 01 Mar 2018 31 May 2018 10-Q 10 Jul 2019 2019 Q3
Q4 2016 $187,000 01 Sep 2016 30 Nov 2016 10-Q 11 Jan 2018 2018 Q1
Q2 2016 $8,000 01 Mar 2016 31 May 2016 10-Q 06 Jul 2017 2017 Q3
Q1 2016 $4,000 01 Dec 2015 29 Feb 2016 10-Q 05 Apr 2017 2017 Q2

ORAMED PHARMACEUTICALS INC. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2019 $90,000 +$176,000 01 Sep 2018 31 Aug 2019 10-K 24 Nov 2020 2020 FY
2018 $86,000 -$273,000 -146% 01 Sep 2017 31 Aug 2018 10-K 27 Nov 2019 2019 FY
2017 $187,000 -$303,000 -62% 01 Sep 2016 31 Aug 2017 10-K 27 Nov 2019 2019 FY
2016 $490,000 01 Sep 2015 31 Aug 2016 10-K 29 Nov 2017 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.